Compare ARK Genomic Revolution ETF (ARKG) vs Mattel Inc (MAT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Mattel Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Mattel Inc trades at $13.36 (market cap $3.87B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Mattel Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | MAT | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $22.16 |
52-Week Low | $23.09 | $13.05 |
Market Cap | — | $3.87B |
Enterprise Value | — | $5.68B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
MAT trades at $13.33, up 1.14% today, with a bearish technical signal from moving averages and oscillators showing neutral RSI levels. The company reported a net income of $397.58M in 2025, with a P/E of 8.54 and ROE of 23.56% indicating solid profitability. Recent news includes expansion of UNO Social Clubs and upcoming Q2 2026 earnings release on August 4, 2026.
The stock presents a mixed outlook: analyst consensus is a Buy with a $14.50 price target, but recent earnings misses and a negative net cash flow of -$145M in 2025 pose risks. Upside potential exists from brand expansions and Comic-Con product launches, while competitive pressures and debt levels of $2.33B require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Mattel Inc
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →
